SPAC4H3.16 Antibody

What is the SPAC4H3.16 gene in Schizosaccharomyces pombe?

SPAC4H3.16 is a gene locus in the fission yeast Schizosaccharomyces pombe that encodes a protein involved in cellular processes. Based on genome annotation studies, it belongs to a family of genes that have been systematically named according to their chromosomal location. The "SPAC" prefix indicates its location on chromosome I of S. pombe, with "4H3.16" denoting its specific position and order within that genomic segment. Understanding this gene's function is critical for researchers exploring fundamental cellular processes in this model organism .

How are antibodies against S. pombe proteins typically generated?

Generation of antibodies against S. pombe proteins like SPAC4H3.16 typically involves expressing the target protein or a specific peptide sequence, followed by immunization in appropriate host animals. For recombinant expression, the gene sequence is codon-optimized, synthesized with appropriate signal peptides, and cloned into expression vectors suitable for mammalian cell lines such as CHO cells or bacterial systems like E. coli. After purification using affinity chromatography (commonly Protein G for antibody fragments), the antigen is used for immunization according to standardized protocols. Monoclonal antibodies can be developed through hybridoma technology, while polyclonal antibodies are directly purified from serum . Researchers frequently validate specificity using genetic knockout strains similar to those described in S. pombe mediator complex studies .

What methods can be used to validate the specificity of a SPAC4H3.16 antibody?

Validating SPAC4H3.16 antibody specificity requires multiple complementary approaches. First, Western blot analysis using both wild-type and SPAC4H3.16 null mutant strains (generated using kanMX or ura4+ selectable markers as demonstrated for other S. pombe genes) provides essential confirmation of specificity . Immunoprecipitation followed by mass spectrometry analysis can identify potential cross-reactivity and confirm the exact epitope recognized. Immunofluorescence microscopy comparing localization patterns between tagged and antibody-detected proteins offers spatial validation. Additionally, ELISA using purified recombinant SPAC4H3.16 protein and related family members can quantitatively measure binding specificity and potential cross-reactivity. Pre-absorption experiments, where the antibody is pre-incubated with its purified antigen before use in applications, can further confirm specificity by demonstrating signal elimination .

How can I optimize Western blot conditions for detecting SPAC4H3.16 protein in yeast extracts?

Optimizing Western blot conditions for SPAC4H3.16 detection requires careful consideration of sample preparation and technical parameters. For efficient protein extraction, S. pombe cells should be disrupted using either glass bead lysis in HB buffer (25mM MOPS pH 7.2, 15mM MgCl₂, 15mM EGTA, 1% Triton X-100, protease inhibitors) or TCA precipitation followed by alkaline lysis. Protein samples (30-50μg) should be separated on 10-12% SDS-PAGE gels, with the percentage adjusted based on the expected molecular weight of SPAC4H3.16. Transfer to PVDF membranes at 100V for 1 hour in cold transfer buffer containing 20% methanol yields optimal results. For blocking, 5% non-fat dry milk in TBST (TBS with 0.1% Tween-20) for 1 hour minimizes background. Primary antibody dilutions should be tested in the range of 1:500 to 1:5000, with overnight incubation at 4°C. After washing with TBST (3×10 minutes), HRP-conjugated secondary antibodies (1:5000-1:10000) should be applied for 1 hour at room temperature . Signal detection via enhanced chemiluminescence allows visualization of SPAC4H3.16, with exposure times optimized based on signal strength.

What is the recommended protocol for immunoprecipitation of SPAC4H3.16 and its interacting partners?

For immunoprecipitation of SPAC4H3.16 and identification of interaction partners, a stringently controlled methodology is essential. Begin by harvesting 50-100ml of S. pombe culture at OD₆₀₀ 0.5-0.8, washing with cold PBS containing phosphatase inhibitors, and lysing in IP buffer (50mM HEPES pH 7.5, 150mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, protease inhibitors) using glass bead disruption. Clear lysate by centrifugation (13,000g, 15 minutes, 4°C) and quantify protein concentration. Pre-clear 2-5mg of total protein with Protein A/G beads for 1 hour at 4°C before incubating with 2-5μg of SPAC4H3.16 antibody overnight at 4°C with gentle rotation. Capture antibody-protein complexes using 30μl Protein A/G beads (pre-equilibrated in IP buffer) for 2 hours at 4°C. After extensive washing (4× with IP buffer, 1× with IP buffer containing 500mM NaCl, 1× with TE buffer), elute bound proteins by boiling in 2× Laemmli buffer or through specific peptide competition . For interaction partner identification, submit samples for mass spectrometry analysis using methods similar to those employed in proteomic studies of antibody repertoires .

How can the SPAC4H3.16 antibody be utilized in ChIP-seq experiments to investigate protein-DNA interactions?

Utilizing SPAC4H3.16 antibody in ChIP-seq experiments requires rigorous methodology to ensure specific and reproducible results. Begin with crosslinking 50ml of mid-log phase S. pombe culture (OD₆₀₀ 0.5-0.8) using 1% formaldehyde for 15 minutes at room temperature, followed by quenching with 125mM glycine for 5 minutes. After harvesting cells, disrupt cell walls enzymatically with zymolyase (10mg/ml in sorbitol buffer) for 30 minutes at 30°C. Lyse spheroplasts in ChIP lysis buffer (50mM HEPES-KOH pH 7.5, 140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, protease inhibitors), and sonicate to generate DNA fragments of 200-500bp. Verify fragmentation efficiency by agarose gel electrophoresis. Immunoprecipitate chromatin from 100μg of sonicated extract using 2-5μg of SPAC4H3.16 antibody pre-bound to protein A/G magnetic beads overnight at 4°C . Include appropriate controls: input chromatin, IgG control, and ideally a SPAC4H3.16 knockout strain. After stringent washing, reverse crosslinks by heating at 65°C overnight in elution buffer containing proteinase K. Purify DNA using column-based methods before library preparation for next-generation sequencing. For data analysis, align reads to the S. pombe genome, identify enriched regions using MACS2 or similar peak-calling software, and perform motif analysis to identify potential binding sites .

What approaches can be used to determine the phosphorylation status of SPAC4H3.16 using phospho-specific antibodies?

Determining the phosphorylation status of SPAC4H3.16 requires generation of phospho-specific antibodies and multiple validation techniques. To develop such antibodies, synthesize phosphopeptides corresponding to predicted phosphorylation sites in SPAC4H3.16, conjugate to carrier proteins like KLH, and immunize rabbits following standard protocols. Purify phospho-specific antibodies using affinity chromatography with both phosphorylated and non-phosphorylated peptides to ensure specificity. Validate antibodies through Western blotting comparing samples treated with and without phosphatase, as well as using site-directed mutagenesis of predicted phosphorylation sites (serine/threonine to alanine; tyrosine to phenylalanine). For detection of in vivo phosphorylation, treat cells with phosphatase inhibitors during sample preparation and perform Western blotting with both phospho-specific and total SPAC4H3.16 antibodies . For comprehensive phosphorylation analysis, immunoprecipitate SPAC4H3.16 from cell lysates and analyze by mass spectrometry using techniques similar to those employed in proteogenomic studies, such as tandem mass spectrometry with phospho-enrichment strategies . Multiple reaction monitoring (MRM) mass spectrometry can quantify specific phosphopeptides across different experimental conditions.

How can SPAC4H3.16 antibody be adapted for STORM or PALM super-resolution microscopy to study protein localization in S. pombe?

Adapting SPAC4H3.16 antibody for super-resolution microscopy requires specific modifications and optimized protocols. For STORM (Stochastic Optical Reconstruction Microscopy), conjugate purified SPAC4H3.16 antibody directly with photoswitchable fluorophores like Alexa Fluor 647 or Cy5/Cy3 pairs using NHS-ester chemistry with a target dye-to-antibody ratio of 1-2 to avoid over-labeling. Alternatively, use secondary antibodies labeled with appropriate fluorophores. For sample preparation, grow S. pombe cells to mid-log phase, fix with 4% paraformaldehyde followed by gentle cell wall digestion (0.5mg/ml zymolyase), and permeabilize with 0.1% Triton X-100. Mount samples in imaging buffer containing oxygen scavenging system (glucose oxidase/catalase) and thiol-containing reducer (MEA or BME) to promote fluorophore blinking behavior . For PALM (Photoactivated Localization Microscopy), generate fusion constructs of SPAC4H3.16 with photoactivatable fluorescent proteins like mEos2 or PAmCherry and express in S. pombe under native promoter control using integrative plasmids similar to those used for Mediator complex studies . Image acquisition requires specialized equipment with high-sensitivity cameras and appropriate laser lines (405nm activation, 561nm or 640nm excitation), collecting thousands of frames for reconstruction. Post-acquisition processing with software like ThunderSTORM or QuickPALM enables molecule localization with ~20nm precision, revealing SPAC4H3.16 distribution patterns inaccessible to conventional microscopy.

How can SPAC4H3.16 antibody be used to study protein-protein interactions through proximity ligation assays?

Proximity Ligation Assay (PLA) with SPAC4H3.16 antibody provides a powerful approach for visualizing and quantifying protein-protein interactions in situ with high sensitivity. Begin by culturing S. pombe cells to mid-log phase, fixing with 3.7% formaldehyde for 20 minutes, and permeabilizing after cell wall digestion. Block cells with 5% BSA in PBS for 1 hour before incubating with primary antibodies: SPAC4H3.16 antibody and an antibody against the suspected interaction partner, ensuring they are derived from different host species (e.g., rabbit anti-SPAC4H3.16 and mouse anti-partner protein). Apply species-specific PLA probes (secondary antibodies conjugated to complementary oligonucleotides) at 1:5 dilution for 1 hour at 37°C. Perform ligation of connector oligonucleotides (30 minutes at 37°C) followed by rolling circle amplification incorporating fluorescent nucleotides (100 minutes at 37°C) . For controls, include samples lacking one primary antibody, use SPAC4H3.16 knockout strains, and test with proteins known not to interact with SPAC4H3.16. Image cells using confocal microscopy, where each fluorescent dot represents a detected interaction. Quantify signals using specialized software like BlobFinder or ImageJ with appropriate plugins to determine interaction frequency under different experimental conditions.

What strategies can resolve contradictory results between antibody-based detection and genetic tagging of SPAC4H3.16?

Resolving contradictory results between antibody-based detection and genetic tagging of SPAC4H3.16 requires systematic troubleshooting and validation approaches. First, validate the SPAC4H3.16 antibody using multiple techniques: Western blotting with knockout controls, peptide competition assays, and immunoprecipitation followed by mass spectrometry . For genetic tags, confirm that the tag doesn't interfere with protein function through complementation tests in knockout strains. Verify tag expression and localization using different tag positions (N-terminal, C-terminal, and internal) and various tag types (e.g., GFP, FLAG, TAP-tag) to rule out tag-specific artifacts . Assess potential epitope masking in antibody detection by testing different fixation methods, antibody concentrations, and epitope retrieval techniques. Consider cell cycle-dependent or condition-specific expression/localization by synchronizing cells and testing under various growth conditions. Use super-resolution microscopy to determine if apparent colocalization is limited by conventional microscopy resolution. For discrepancies in protein abundance, combine absolute quantification approaches using recombinant protein standards with both antibody detection and tag-based methods. If contradictions persist, employ orthogonal techniques such as RNA-seq for transcription analysis and ribosome profiling for translation assessment to provide context for protein-level observations .

How can phosphoproteomic approaches be combined with SPAC4H3.16 antibody to map signaling networks?

Integrating phosphoproteomic approaches with SPAC4H3.16 antibody studies enables comprehensive mapping of associated signaling networks. Begin by performing large-scale immunoprecipitation of SPAC4H3.16 from S. pombe cultures treated with phosphatase inhibitors under different conditions (e.g., nutrient limitation, stress response, cell cycle arrest). Process immunoprecipitated samples for phosphopeptide enrichment using titanium dioxide (TiO₂) or immobilized metal affinity chromatography (IMAC) before LC-MS/MS analysis on high-resolution instruments . Analyze data using specialized software like MaxQuant with PTM scoring algorithms to identify phosphorylation sites on SPAC4H3.16 and co-precipitating proteins. To determine which kinases might target SPAC4H3.16, utilize phospho-motif analysis tools (e.g., Scansite, NetPhos) followed by validation with specific kinase inhibitors or kinase deletion strains. For temporal dynamics, implement a SILAC or TMT-based quantitative phosphoproteomic approach across relevant time points. Validate key phosphorylation events using phospho-specific antibodies in Western blotting and immunofluorescence . Construct a comprehensive signaling network by combining phosphoproteomic data with protein-protein interaction information from BioGRID and other databases. Network perturbation experiments, where specific kinases or phosphatases are inhibited or deleted, can further elucidate the functional consequences of phosphorylation events in the SPAC4H3.16-associated signaling network .

How can single-cell proteomics approaches be used with SPAC4H3.16 antibody to study cell-to-cell variation?

Adapting single-cell proteomics approaches for SPAC4H3.16 studies provides unprecedented insights into cell-to-cell heterogeneity. Begin by optimizing a protocol for gentle isolation of individual S. pombe cells from asynchronous cultures using microfluidic devices or flow cytometry sorting. For antibody-based approaches, implement single-cell Western blotting using specialized microwell arrays, where isolated cells are lysed in situ, proteins separated by size, and SPAC4H3.16 detected using validated antibodies with fluorescent secondary detection . Alternatively, employ mass cytometry (CyTOF) by conjugating SPAC4H3.16 antibody with rare earth metals and combining with antibodies against other proteins of interest and cell cycle markers. For higher throughput, adapt the proteogenomic Alicanto platform approach to single-cell analysis by developing a workflow that combines single-cell protein extraction with mass spectrometry identification of SPAC4H3.16 and its modification states . Implement computational approaches similar to those used in antibody repertoire analysis to identify patterns across cell populations. For functional context, combine these approaches with single-cell RNA-seq in matched cell populations to correlate transcriptomic and proteomic variations. This integrated approach can reveal whether SPAC4H3.16 expression, localization, or modification heterogeneity correlates with specific cellular states or transitions, particularly during cell cycle progression or in response to environmental stresses .

What are the best practices for using SPAC4H3.16 antibody in CODEX or MIBI multiplexed tissue imaging systems?

Adapting SPAC4H3.16 antibody for multiplexed tissue imaging requires specific optimization procedures and controls. For CODEX (CO-Detection by indEXing) applications, conjugate purified SPAC4H3.16 antibody with DNA barcodes containing specific sequences compatible with the CODEX system using NHS-ester chemistry at a 2:1 barcode:antibody ratio. Test multiple conjugation conditions to identify optimal signal-to-noise ratios. For tissue preparation, fix S. pombe cells embedded in agarose blocks with 4% paraformaldehyde followed by gentle permeabilization, ensuring cellular architecture preservation . In the staining protocol, use appropriate buffers with protein blockers to minimize background and include validated controls: SPAC4H3.16 knockout strains, competitive blocking with immunizing peptide, and isotype controls. For Multiplexed Ion Beam Imaging (MIBI), conjugate SPAC4H3.16 antibody with isotopically pure elemental metals like lanthanides using metal-chelating polymers. Validate metal-conjugated antibodies using traditional immunofluorescence before MIBI application . During imaging, collect data across multiple fields of view to account for spatial heterogeneity. For analysis, use supervised machine learning algorithms to identify cell types and quantify SPAC4H3.16 expression patterns across single cells. Integration with multiplex data from other proteins allows construction of spatial protein interaction networks and identification of microenvironmental factors influencing SPAC4H3.16 expression or localization .

How can cryo-electron tomography be combined with SPAC4H3.16 immunogold labeling to study protein complexes?

Combining cryo-electron tomography (cryo-ET) with SPAC4H3.16 immunogold labeling provides revolutionary insights into the three-dimensional ultrastructural context of protein complexes. Begin by converting SPAC4H3.16 antibody to Fab fragments using papain digestion to reduce the label size and improve accessibility in crowded cellular environments. Conjugate these Fab fragments with ultrasmall gold particles (1-3nm) using maleimide chemistry targeting reduced hinge-region disulfides . For cell preparation, culture S. pombe to mid-log phase, treat with mild cell wall digestive enzymes to improve antibody penetration, and apply SPAC4H3.16-gold conjugates before vitrification by plunge-freezing in liquid ethane. Alternatively, implement the CEMOVIS (Cryo-Electron Microscopy of Vitreous Sections) technique for thicker samples. Collect tilt series on a cryo-electron microscope equipped with a direct electron detector, rotating the sample from -60° to +60° in 2° increments at low electron doses (≤100 e⁻/Ų) . Generate tomograms through weighted back-projection or SIRT reconstruction, and locate gold particles using template matching algorithms. For validation, perform correlative light and electron microscopy (CLEM) using SPAC4H3.16 labeled with both fluorescent tags and gold particles. Subtomogram averaging of multiple instances of SPAC4H3.16-containing complexes can reveal structural details at sub-nanometer resolution. This approach is particularly valuable for studying the structural incorporation of SPAC4H3.16 in large macromolecular assemblies, providing insights impossible to obtain through traditional structural biology methods .